Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria
Plant-derived lignans, consumed daily by most individuals, are thought to protect against cancer and other diseases 1 ; however, their bioactivity requires gut bacterial conversion to enterolignans 2 . Here, we dissect a four-species bacterial consortium sufficient for all five reactions in this pat...
Saved in:
Published in | Nature microbiology Vol. 5; no. 1; pp. 56 - 66 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.01.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Plant-derived lignans, consumed daily by most individuals, are thought to protect against cancer and other diseases
1
; however, their bioactivity requires gut bacterial conversion to enterolignans
2
. Here, we dissect a four-species bacterial consortium sufficient for all five reactions in this pathway. A single enzyme (benzyl ether reductase, encoded by the gene
ber
) was sufficient for the first two biotransformations, variable between strains of
Eggerthella lenta
, critical for enterolignan production in gnotobiotic mice and unique to Coriobacteriia. Transcriptional profiling (RNA sequencing) independently identified
ber
and genomic loci upregulated by each of the remaining substrates. Despite their low abundance in gut microbiomes and restricted phylogenetic range, all of the identified genes were detectable in the distal gut microbiomes of most individuals living in northern California. Together, these results emphasize the importance of considering strain-level variations and bacterial co-occurrence to gain a mechanistic understanding of the bioactivation of plant secondary metabolites by the human gut microbiome.
A consortium of four human gut microbiota species, including
Eggerthella lenta
, can convert plant-derived lignans into bioactive enterolignans via a five-step pathway, providing mechanistic insight into the production of these protective metabolites. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 E.N.B. performed or supervised all of the experimental work. J.E.B. performed the bioinformatic analyses and performed a subset of experimental work. S.N. developed the metagenome database. P.S. assisted with bacterial culturing and heterologous expression. F.Y. and A.B. designed and implemented the culture-independent assays for gene prevalence. F.Y. performed the ex vivo incubations. E.W. generated bacterial mutants. B.E.R. performed mass spectrometry on bacterial cultures. X.L. and A.A.F. performed mass spectrometry on mouse samples. Q.A. extracted DNA from human samples collected by D.L.A. and S.K.K. S.K. and D.W.W. synthesized dmSECO. P.J.T. supervised the study. Author contributions |
ISSN: | 2058-5276 2058-5276 |
DOI: | 10.1038/s41564-019-0596-1 |